The Plain Dealer highlights new CWRU, Haima Therapeutics agreement to develop a blood-clotting platelet simulator that could save lives

Cleveland, OH. June 7, 2018. CWRU and Haima Therapeutics have agreed that Haima can license SynthoPlate, an artificial platelet product. The Plain Dealer, the prime Cleveland news source, interviewed the inventor/Co-Founder, Dr. Anirban Sen Gupta, and Co-Founder and CSO, Dr. Christa Pawlowski. 

See the full story at